Video

Role of Second Generation FLT3 Inhibitors in AML

Author(s):

Alexandra S. Wolff, PharmD, BCOP

Expert examines the status of second-generation FLT3 inhibitors in newly diagnosed AML patients and the challenge with comparing clinical trial efficacy endpoints.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © nimito - stock.adobe.com
Image Credit: © Beaunitta Van Wyk/peopleimages.com - stock.adobe.com
Image Credit: © sofiko14 - stock.adobe.com
Image Credit: © hamad - stock.adobe.com
Image Credit: © Anastasiia - stock.adobe.com
hematological cancer/Image Credit: © nikola-master - stock.adobe.com
lymphoma, OPC, ASCO 2024, hodgkin lymphoma
Related Content
From Dogs to Human: AI-Powered Drug Response Prediction Technology Shows Improved Clinical Outcomes in Oncology
December 2nd 2024

From Dogs to Humans: AI-Powered Drug Response Prediction Technology Demonstrates Improved Clinical Outcomes in Oncology

Alana Hippensteele, Managing Editor
Pharmacy Focus Oncology: Advancements in Hematology and Breast Cancer - ASH and SABCS 2023 Recap
January 29th 2024

Pharmacy Focus Oncology: Advancements in Hematology and Breast Cancer - ASH and SABCS 2023 Recap

Vial of methylene blue solution | Image Credit: © Sanhanat - stock.adobe.com
November 27th 2024

FDA Approves Methylene Blue Injection for Acquired Methemoglobinemia

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Oncology Edition - Experts See Promising Future for the Treatment of Acute Lymphoblastic Leukemia
September 26th 2022

Pharmacy Focus: Oncology Edition - Experts See Promising Future for the Treatment of Acute Lymphoblastic Leukemia

FDA homepage -- Image credit: Postmodern Studio | stock.adobe.com
November 25th 2024

FDA Approves Oral Liquid Solution of Imatinib for Certain Forms of Leukemia and Other Cancers

Gillian McGovern, Assistant Editor
The Role of Social Determinants of Health in Pediatric Stem Cell Transplantation: Bridging Gaps in Care
November 24th 2024

The Role of Social Determinants of Health in Pediatric Stem Cell Transplantation: Bridging Gaps in Care

Alana Hippensteele, Managing Editor